NCT03243006COMPLETEDanonymous

Effect of Early Analgesic Treatment on Opioid Consumption

Sponsor

Source record

University of Monastir

Phase

Source record

Modality

AI-normalized

small molecule

Target

AI-normalized

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Indication / condition

AI-normalized

Acute Pain

Intervention

Source record

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Related intelligence directories

Indication directory: Acute Pain Modality directory: small molecule Target directory: Paracetamol

Source & freshness

Source record

NCT ID

NCT03243006

Original source

ClinicalTrials.gov

Source last updated

Nov 30, 2017

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT03243006

Title

Effect of Early Analgesic Treatment on Opioid Consumption

Sponsor

University of Monastir

Status

COMPLETED

Phase

Condition raw

Acute Pain

Condition normalized

Acute Pain

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Target normalized

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Interventions

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Public preview

Source record

introduction: Pain remains one of the most common reasons of emergency department admission. Opioids are overprescribed in emergency departments to treat severe pain.

objective: assessing the impact of ealy pain pain management on the use of intravenous morphine and on patient satisfaction.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Effect of Early Analgesic Treatment on Opioid Consumption

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT03243006

Status

COMPLETED

Phase

Sponsor

University of Monastir

Executive brief

Investment-Ready Snapshot

introduction: Pain remains one of the most common reasons of emergency department admission. Opioids are overprescribed in emergency departments to treat severe pain. objective: assessing the impact of ealy pain pain management on the use of intravenous morphine and on patient satisfaction.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedNov 30, 2017

Internal syncJun 09, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03243006

Indication

Acute Pain

Modality

small molecule

Target

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Intervention

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.